{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262944921701760.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.2967/jnumed.118.210443"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.2967/jnumed.118.210443"}}],"dc:title":[{"@value":"Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262944921701761","@type":"Researcher","foaf:name":[{"@value":"Thomas Lindner"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701889","@type":"Researcher","foaf:name":[{"@value":"Anastasia Loktev"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701893","@type":"Researcher","foaf:name":[{"@value":"Annette Altmann"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701892","@type":"Researcher","foaf:name":[{"@value":"Frederik Giesel"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701891","@type":"Researcher","foaf:name":[{"@value":"Clemens Kratochwil"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701890","@type":"Researcher","foaf:name":[{"@value":"Jürgen Debus"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701760","@type":"Researcher","foaf:name":[{"@value":"Dirk Jäger"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701888","@type":"Researcher","foaf:name":[{"@value":"Walter Mier"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944921701894","@type":"Researcher","foaf:name":[{"@value":"Uwe Haberkorn"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01615505"},{"@type":"EISSN","@value":"2159662X"}],"prism:publicationName":[{"@value":"Journal of Nuclear Medicine"}],"dc:publisher":[{"@value":"Society of Nuclear Medicine"}],"prism:publicationDate":"2018-04-06","prism:volume":"59","prism:number":"9","prism:startingPage":"1415","prism:endingPage":"1422"},"reviewed":"false","url":[{"@id":"https://syndication.highwire.org/content/doi/10.2967/jnumed.118.210443"}],"createdAt":"2018-04-06","modifiedAt":"2022-08-18","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360017280668753408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of 68Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017280672796160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Associations between Normal Organs and Tumor Burden in Patients Imaged with Fibroblast Activation Protein Inhibitor-Directed Positron Emission Tomography"}]},{"@id":"https://cir.nii.ac.jp/crid/1360022307171765888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fibroblast Activation Protein Targeted Therapy Using [177Lu]FAPI-46 Compared with [225Ac]FAPI-46 in a Pancreatic Cancer Model"}]},{"@id":"https://cir.nii.ac.jp/crid/1360298757187196416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"PET Imaging of Estrogen Receptors for Gynecological Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360299451928749440","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical value of [18F]AlF-NOTA-FAPI-04 PET/CT for assessing early-stage liver fibrosis in adult liver transplantation recipients compared with chronic HBV patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865727392000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and Piperazine"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302866843816320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360850094268628864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: <sup>64</sup>Cu- and <sup>225</sup>Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814740005376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Fibroblast Activation Protein Inhibitor Theranostics"}]},{"@id":"https://cir.nii.ac.jp/crid/1390583790037619968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"GMP-Compliant Automated Radiolabeling and Quality Controls of [<sup>68</sup>Ga]Ga-FAPI-46 for Fibroblast Activation Protein-Targeted PET Imaging in Clinical Settings"}]},{"@id":"https://cir.nii.ac.jp/crid/2050307417136278272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Substrate study for dihydroxyboryl astatine substitution reaction with fibroblast activation protein inhibitor (FAPI)"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.2967/jnumed.118.210443"},{"@type":"CROSSREF","@value":"10.1097/rlu.0000000000004480_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.3390/cancers14112609_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1097/rlu.0000000000004258_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1007/s11604-024-01528-0_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.3390/ijms24108701_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1007/s00259-023-06245-w_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.2967/jnumed.119.233122_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1007/s00259-021-05554-2_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1246/cl.220391_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1248/cpb.c24-00531_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"},{"@type":"CROSSREF","@value":"10.1016/j.cpet.2023.02.005_references_DOI_M8DO7QJrLswir5a1CjieabstwYx"}]}